MedTrace Logo

Evaluation of Cerebral Thrombembolism After TAVR

NCT02758964 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2019-04-02

No results posted yet for this study

Summary

EARTH-TAVR is a diagnostic multicenter study to evaluate the occurrence and extent of cerebral embolization (total new lesion volume) in patients before TAVR versus 3 months after TAVR.

Conditions

  • Aortic Valve Stenosis
  • Transcatheter Aortic Valve Replacement
  • Intracranial Embolism

Interventions

OTHER

MRI, neurocognitive Testing

A cerebral MRI and neurocognitive testing will be performed before TAVR, before hospital discharge and after 3 months

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Ulf Landmesser, Prof. Dr. · Charité - Universitätsmedizin Berlin, Department of Cardiology

  • Matthias Endres, Prof. Dr. · Charité - Universitätsmedizin Berlin, Department of Neurology

  • Georg M Fröhlich, PD · Charité - Universitätsmedizin Berlin, Department of Cardiology

  • Volkmar Falk, Professor · German Heart Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2019-01-31
Completion
2019-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02758964 on ClinicalTrials.gov